Q4 2025 · CIK 1569205 Snapshot · — Export CSV
Manager file · FS · Fundsmith LLP

Terry Smith - Fundsmith

EDGAR CIK 1569205 ↗ · Filed · typical filing lag 45 days

Export CSV
Reported portfolio value
$17.12B
QoQ reported -13.5% · vs Q3 2025
Positions
37
2 new · 0 exited
Top 10 concentration
66.9%
largest position 7.9%
Position churn · Q4 2025
4 added · 22 trimmed
new positions 0.6% · exits 0.0% of book
Holdings · Q4 2025 · 37
Security Weight Δ wt Price* Shares Δ shares Value Action
1 WAT WATERS CORP 7.90% +1.9% $380 3.56M -10.0% $1.35B Trimmed
2 SYK STRYKER CORPORATION 7.57% -1.0% $351 3.69M -19.7% $1.30B Trimmed
3 IDXX IDEXX LABS INC 7.42% -1.0% $677 1.88M -28.1% $1.27B Trimmed
4 V VISA INC 7.24% +0.6% $351 3.53M -8.3% $1.24B Trimmed
5 MAR MARRIOTT INTL INC NEW 7.21% +1.7% $310 3.98M -5.9% $1.23B Trimmed
6 GOOGL ALPHABET INC 6.40% -1.3% $313 3.50M -44.4% $1.10B Trimmed
7 ADP AUTOMATIC DATA PROCESSING IN 6.28% -0.1% $257 4.18M -3.1% $1.07B Trimmed
8 MSFT MICROSOFT CORP 5.88% -0.9% $484 2.08M -19.5% $1.01B Trimmed
9 PM PHILIP MORRIS INTL INC 5.74% -0.2% $160 6.12M -14.8% $982M Trimmed
10 META META PLATFORMS INC 5.26% -0.5% $660 1.36M -12.5% $900M Trimmed
11 MTD METTLER TOLEDO INTERNATIONAL 4.73% +1.1% $1.39K 581K -1.7% $809M Trimmed
12 PG PROCTER AND GAMBLE CO 3.56% +0.0% $143 4.25M -7.2% $609M Trimmed
13 CHD CHURCH AND DWIGHT CO INC 3.30% +0.3% $84 6.73M -1.0% $564M Trimmed
14 FTNT FORTINET INC 3.02% -0.6% $79 6.52M -22.6% $517M Trimmed
15 ZTS ZOETIS INC 2.87% +0.2% $126 3.90M +7.9% $491M Added
16 TXN TEXAS INSTRS INC 2.66% +0.1% $173 2.62M -3.6% $455M Trimmed
17 INTU INTUIT 2.42% +0.3% $662 626K +3.5% $414M Added
18 NKE NIKE INC 2.15% -0.0% $64 5.77M -5.9% $368M Trimmed
19 OTIS OTIS WORLDWIDE CORP 1.59% -1.1% $87 3.11M -46.5% $272M Trimmed
20 MSCI MSCI INC 0.56% +0.1% $574 167K +0.0% $95.59M Held
21 ROL ROLLINS INC 0.52% +0.1% $60 1.48M +0.0% $88.75M Held
22 QLYS QUALYS INC 0.50% -0.1% $133 648K -25.6% $86.09M Trimmed
23 PAYC PAYCOM SOFTWARE INC 0.49% -0.1% $159 523K +0.0% $83.41M Held
24 — ODDITY TECH LTD 0.49% +0.0% $40 2.07M +46.4% $83.34M Added
25 CPRXEUR CATALYST PHARMACEUTICALS INC 0.46% +0.1% $23 3.36M +0.0% $78.51M Held
26 NSSC NAPCO SEC TECHNOLOGIES INC 0.43% +0.0% $42 1.78M +0.0% $74.22M Held
27 DOCS DOXIMITY INC 0.43% -0.1% $44 1.65M +21.7% $73.06M Added
28 NTNX NUTANIX INC 0.42% +0.4% $52 1.38M new $71.19M New
29 VRT VERTIV HOLDINGS CO 0.39% -0.1% $162 411K -30.5% $66.58M Trimmed
30 VRSN VERISIGN INC 0.38% +0.0% $243 271K +0.0% $65.75M Held
31 CLX CLOROX CO DEL 0.36% -0.0% $101 613K +0.0% $61.86M Held
32 MANH MANHATTAN ASSOCIATES INC 0.29% -0.0% $173 288K +0.0% $49.97M Held
33 GGG GRACO INC 0.28% -0.1% $82 579K -35.7% $47.46M Trimmed
34 MEDP MEDPACE HLDGS INC 0.27% -0.1% $562 83K -35.3% $46.37M Trimmed
35 ADMA ADMA BIOLOGICS INC 0.22% +0.2% $18 2.10M new $38.34M New
36 SABR SABRE CORP 0.17% -0.0% $1 21.50M +0.0% $29.24M Held
37 HD HOME DEPOT INC 0.16% -0.0% $344 80K -5.5% $27.60M Trimmed

* Price = reported value ÷ shares at quarter end (13F does not disclose cost basis). Δ wt = this position's share of the reported portfolio versus the prior quarter. Options are shown separately when filed.

This quarter's moves
  • NUTANIX INC 0.42% · $71.19M
  • ADMA BIOLOGICS INC 0.22% · $38.34M
  • none reported
  • Filing detail
    Period2025-12-31
    Accepted17 Feb 2026 · 08:05 ET
    Filing lag48 days
    Form13F-HR
    Information rows37
    Quarters on file8
    Portfolio value
    Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026$23.46B Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 202642
    Quarterly history · 8 filings
    QuarterPeriod endReported valuePositionsLargestNewExitedFiledLag
    Q3 2026 2026-09-30 $12.92B 42 7.7% 2 1 16 Nov 2026 ET 47
    Q2 2026 2026-06-30 $13.65B 41 7.0% 13 6 14 Aug 2026 ET 45
    Q1 2026 2026-03-31 $12.83B 34 8.6% 1 4 15 May 2026 ET 45
    Q4 2025 2025-12-31 $17.12B 37 7.9% 2 0 17 Feb 2026 ET 48
    Q3 2025 2025-09-30 $19.80B 35 8.6% 0 4 14 Nov 2025 ET 45
    Q2 2025 2025-06-30 $23.02B 39 11.4% 3 2 14 Aug 2025 ET 45
    Q1 2025 2025-03-31 $21.97B 38 10.2% 2 2 15 May 2025 ET 45
    Q4 2024 2024-12-31 $23.46B 38 11.4% — — 14 Feb 2025 ET 45
    Track record · return since filing
    Paper return of each reported book
    Since Q4 2024
    +16.4%
    S&P 500 +24.1%
    Hit rate · latest book
    0%
    priced positions with positive return
    Priced coverage
    100%
    of reported stock value
    Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026Reported bookS&P 500
    Quarter by quarter
    QuarterBookS&P 500ExcessCoverageBest call
    Q3 2026 +0.0% +0.0% +0.0% 100% WAT +0.0%
    Q2 2026 +3.8% -4.1% +8.0% 100% MAR +19.8%
    Q1 2026 +20.1% +0.9% +19.1% 100% MTD +67.8%
    Q4 2025 +16.6% +9.6% +7.0% 99% WAT +41.8%
    Q3 2025 +14.0% +11.7% +2.3% 99% MAR +50.5%
    Q2 2025 +12.8% +16.7% -3.8% 99% MAR +61.7%
    Q1 2025 +15.6% +27.8% -12.2% 99% GOOGL +75.6%
    Q4 2024 +16.4% +24.1% -7.8% 100% MSFT +29.4%
    Copy-trade simulation
    Hypothetical strategy
    +28.9%
    8 rebalances
    S&P 500 same window
    +24.1%
    excess +4.7%

    Simulation: at each filing date, buy the manager's ten largest reported common-stock positions in equal weight; hold until the next filing. Prices are split- and dividend-adjusted closes. It ignores the 45-day disclosure lag's cost to a real copycat beyond the filing-date entry, taxes, fees and liquidity. It is a reading aid, not a backtest of the manager's fund.